PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid
Source abstract
Abstract
There is a broad interest in the development of nanoparticles (NPs) carrying on their surface carbohydrates such as sialic acids. It is known that these carbohydrates influence the biological and physical properties of biopharmaceutical proteins and living cells. Macromolecular compounds containing these carbohydrates showed an anti-recognition effect, exert an antiviral effect and also are able to be recognized by the cell surface of some kind of cancer cells. Thus, in the present research we performed two different approaches in order to obtain polymeric (poly(D,L-lactide-co-glycolide), PLGA) NPs surface decorated with the sialic acid N-acetylneuraminic acid (Neu5Ac). The first strategy that has been followed is based on the derivatization of the polyester PLGA with the thioderivative of Neu5Ac, starting material for the preparation of the NPs; the second is based on the synthesis of compounds potentially able to insert their lipophilic moiety into the underivatized PLGA NPs during their preparation, and to display their hydrophilic moiety (Neu5Ac) on their surface. The first approach allowed the obtainment of NPs surface decorated with Neu5Ac, as evidenced by ESCA spectroscopy and interaction with the lectin Wheat Germ Agglutinin. Moreover, a formulation of these NPs suitable for in vitro assays showed that they are phagocytosed by human monocytes with an apparently different mechanism with respect of those made of underivatized PLGA. The second strategy led to NPs in which their surface appears to be very different with respect to the NPs obtained following the first strategy, with the carboxylic groups of Neu5Ac markedly shielded. Thus, the new Neu5Ac-modified PLGA polyester represent a useful starting material for the preparation of NPs surface decorated with this sialic acid.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Glycosylation and Glycoproteins Research · Biopolymer Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Sialic acid: the chemical neurobiology of carbohydrates10.1021/cr078215f ↗
2. The synthesis and glycosidation of N-acetylneuraminic acid10.1055/s-1991-26522 ↗
3. Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells10.1016/j.drudis.2007.02.010 ↗
4. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids10.1016/j.ijpharm.2005.06.007 ↗
5. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes10.1016/j.jconrel.2006.08.001 ↗
6. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
7. Long-circulating and target-specific nanoparticles: theory to practice10.1016/S0031-6997(24)01494-7 ↗
8. Synthesis and function of sialic acid-conjugated cholesterols as ganglioside analogs: their reconstitution to liposomes and interaction with rat lymphocytes10.2183/pjab.76.63 ↗
9. Synthesis of new α-thiosialodendrimers and their binding properties to the sialic acid specific lectin from Limax flavus10.1021/ja963874n ↗
10. Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties10.1016/j.bmc.2009.06.036 ↗
11. Synthesis of sialoclusters appended to calyx[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses10.1039/b800598b ↗
12. Inhibition of Influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates10.1139/m91-035 ↗
13. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition10.1021/jm00021a007 ↗
14. Synthesis and anti-influenza virus activity of novel glycopolymers having triantennary oligosaccharide branches10.1039/b002412k ↗
15. Synthesis of sialic acid derivatives having a CC double bond substituted at the C-5 position and their glycopolymers10.1016/j.bmcl.2009.07.034 ↗
16. Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus10.1023/A:1006960116583 ↗
17. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(l-glutamic acid) backbone for inhibition of infection by influenza viruses10.1093/glycob/cwg032 ↗
18. Chemoenzymatic synthesis of artificial glycopeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses10.1016/j.bmc.2006.11.006 ↗
19. Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection10.1021/jm8000967 ↗
20. Targeted sialic acid-Doxorubicin Prodrugs for intracellular delivery and cancer treatment10.1007/s11095-007-9406-1 ↗
21. Polymeric systems for controlled drug release10.1021/cr940351u ↗
22. Controlled ring-opening polymerization of lactide and glycolide10.1021/cr040002s ↗
23. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles10.1016/S0378-5173(01)00676-7 ↗
24. New ganglioside analogs that inhibit influenza virus sialidase10.1007/BF01073378 ↗
25. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labelling and biodistribution studies10.1080/10611860801899300 ↗
26. Chemical modification of chitosan: preparation of chitosan-sialic acid branched polysaccharide hybrids10.1039/b001861i ↗
27. Synthese anomerer sialinsaure-methylketoside10.1002/cber.19660990235 ↗
28. Studies on the thioglycosides of N-acetylneuraminic acid 1: synthesis of alkyl a-glycosides of 2-thio-N-acetylneuraminic acid10.1080/07328308608082638 ↗
29. Stereoselective synthesis of 2-thioglycosides of N-acetylneuraminic acid10.1016/0008-6215(89)80054-0 ↗
30. Synthesis and evaluation of N-acetylneuraminic acid-based affinity matrices for the purification of sialic acid-recognizing proteins10.1023/A:1006932330367 ↗
31. Practical synthetic route to functionalized rhodamine dyes10.1021/ol035135z ↗
32. Nanocapsule formation by interfacial polymer deposition following solvent displacement10.1016/0378-5173(89)90281-0 ↗
33. Single-step process to produce surface-functionalized polymeric nanoparticles10.1021/la701997x ↗
34. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs10.1016/j.biomaterials.2003.09.055 ↗
35. XPS and wettability characterization of modified poly(lactic acid) and poly(lactic/glycolic acid) films10.1006/jcis.2001.7954 ↗
36. Probing the surface chemical structure of the novel biodegradable polymer poly(β-malic acid) and its ester derivatives using ToF-SIMS and XPS10.1021/ma9702612 ↗
37. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy10.1021/bm050953v ↗
38. Biocompatible polymeric micelles with Polysorbate 80 for use in brain targeting10.1088/0957-4484/19/48/485603 ↗
39. Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor10.1021/jm049481d ↗
40. Polysaccharide-decorated nanoparticles10.1016/j.ejpb.2004.02.016 ↗
41. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
42. Stealthy liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties10.1016/S0163-7827(03)00033-X ↗